357 related articles for article (PubMed ID: 33544004)
1. The failings of
Arkell TR; Spindle TR; Kevin RC; Vandrey R; McGregor IS
Traffic Inj Prev; 2021; 22(2):102-107. PubMed ID: 33544004
[TBL] [Abstract][Full Text] [Related]
2. Cannabis effects on driving lateral control with and without alcohol.
Hartman RL; Brown TL; Milavetz G; Spurgin A; Pierce RS; Gorelick DA; Gaffney G; Huestis MA
Drug Alcohol Depend; 2015 Sep; 154():25-37. PubMed ID: 26144593
[TBL] [Abstract][Full Text] [Related]
3. Effect of Cannabidiol and Δ9-Tetrahydrocannabinol on Driving Performance: A Randomized Clinical Trial.
Arkell TR; Vinckenbosch F; Kevin RC; Theunissen EL; McGregor IS; Ramaekers JG
JAMA; 2020 Dec; 324(21):2177-2186. PubMed ID: 33258890
[TBL] [Abstract][Full Text] [Related]
4. Cognition and motor control as a function of Delta9-THC concentration in serum and oral fluid: limits of impairment.
Ramaekers JG; Moeller MR; van Ruitenbeek P; Theunissen EL; Schneider E; Kauert G
Drug Alcohol Depend; 2006 Nov; 85(2):114-22. PubMed ID: 16723194
[TBL] [Abstract][Full Text] [Related]
5. Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition.
Arkell TR; Lintzeris N; Kevin RC; Ramaekers JG; Vandrey R; Irwin C; Haber PS; McGregor IS
Psychopharmacology (Berl); 2019 Sep; 236(9):2713-2724. PubMed ID: 31044290
[TBL] [Abstract][Full Text] [Related]
6. Simulated driving performance among daily and occasional cannabis users.
Brooks-Russell A; Brown T; Friedman K; Wrobel J; Schwarz J; Dooley G; Ryall KA; Steinhart B; Amioka E; Milavetz G; Sam Wang G; Kosnett MJ
Accid Anal Prev; 2021 Sep; 160():106326. PubMed ID: 34403895
[TBL] [Abstract][Full Text] [Related]
7. "Residual blood THC levels in frequent cannabis users after over four hours of abstinence: A systematic review.".
Peng YW; Desapriya E; Chan H; R Brubacher J
Drug Alcohol Depend; 2020 Nov; 216():108177. PubMed ID: 32841811
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of divided attention psychophysical task performance and effects on pupil sizes following smoked, vaporized and oral cannabis administration.
Newmeyer MN; Swortwood MJ; Taylor ME; Abulseoud OA; Woodward TH; Huestis MA
J Appl Toxicol; 2017 Aug; 37(8):922-932. PubMed ID: 28138971
[TBL] [Abstract][Full Text] [Related]
9. Detection of Δ
Arkell TR; Kevin RC; Stuart J; Lintzeris N; Haber PS; Ramaekers JG; McGregor IS
Drug Test Anal; 2019 Oct; 11(10):1486-1497. PubMed ID: 31442003
[TBL] [Abstract][Full Text] [Related]
10. Effect of Blood Collection Time on Measured Δ9-Tetrahydrocannabinol Concentrations: Implications for Driving Interpretation and Drug Policy.
Hartman RL; Brown TL; Milavetz G; Spurgin A; Gorelick DA; Gaffney GR; Huestis MA
Clin Chem; 2016 Feb; 62(2):367-77. PubMed ID: 26823611
[TBL] [Abstract][Full Text] [Related]
11. [Time profile of serum THC levels in occasional and chronic marihuana smokers after acute drog use - implication for drivind motor vehicles].
Balíková M; Hložek T; Páleníček T; Tylš F; Viktorinová M; Melicher T; Androvičová R; Tomíček P; Roman M; Horáček J
Soud Lek; 2014; 59(1):2-6. PubMed ID: 24625019
[TBL] [Abstract][Full Text] [Related]
12. Cannabis effects on driving longitudinal control with and without alcohol.
Hartman RL; Brown TL; Milavetz G; Spurgin A; Pierce RS; Gorelick DA; Gaffney G; Huestis MA
J Appl Toxicol; 2016 Nov; 36(11):1418-29. PubMed ID: 26889769
[TBL] [Abstract][Full Text] [Related]
13. Correlation between oral fluid and blood THC concentration: A systematic review and discussion of policy implications.
Robertson MB; Li A; Yuan Y; Jiang A; Gjerde H; Staples JA; Brubacher JR
Accid Anal Prev; 2022 Aug; 173():106694. PubMed ID: 35640367
[TBL] [Abstract][Full Text] [Related]
14. A semi-naturalistic open-label study examining the effect of prescribed medical cannabis use on simulated driving performance.
Manning B; Arkell TR; Hayley AC; Downey LA
J Psychopharmacol; 2024 Mar; 38(3):247-257. PubMed ID: 38332655
[TBL] [Abstract][Full Text] [Related]
15. Developing limits for driving under cannabis.
Grotenhermen F; Leson G; Berghaus G; Drummer OH; Krüger HP; Longo M; Moskowitz H; Perrine B; Ramaekers JG; Smiley A; Tunbridge R
Addiction; 2007 Dec; 102(12):1910-7. PubMed ID: 17916224
[TBL] [Abstract][Full Text] [Related]
16. Assessment of driving capability through the use of clinical and psychomotor tests in relation to blood cannabinoids levels following oral administration of 20 mg dronabinol or of a cannabis decoction made with 20 or 60 mg Delta9-THC.
Ménétrey A; Augsburger M; Favrat B; Pin MA; Rothuizen LE; Appenzeller M; Buclin T; Mangin P; Giroud C
J Anal Toxicol; 2005; 29(5):327-38. PubMed ID: 16105257
[TBL] [Abstract][Full Text] [Related]
17. Biomarkers of Recent Cannabis Use in Blood, Oral Fluid and Breath.
Hubbard JA; Hoffman MA; Ellis SE; Sobolesky PM; Smith BE; Suhandynata RT; Sones EG; Sanford SK; Umlauf A; Huestis MA; Grelotti DJ; Grant I; Marcotte TD; Fitzgerald RL
J Anal Toxicol; 2021 Sep; 45(8):820-828. PubMed ID: 34185831
[TBL] [Abstract][Full Text] [Related]
18. Cannabis use: a perspective in relation to the proposed UK drug-driving legislation.
Wolff K; Johnston A
Drug Test Anal; 2014; 6(1-2):143-54. PubMed ID: 24327278
[TBL] [Abstract][Full Text] [Related]
19. Extended plasma cannabinoid excretion in chronic frequent cannabis smokers during sustained abstinence and correlation with psychomotor performance.
Karschner EL; Swortwood MJ; Hirvonen J; Goodwin RS; Bosker WM; Ramaekers JG; Huestis MA
Drug Test Anal; 2016 Jul; 8(7):682-9. PubMed ID: 26097154
[TBL] [Abstract][Full Text] [Related]
20. Acute Pharmacokinetic Profile of Smoked and Vaporized Cannabis in Human Blood and Oral Fluid.
Spindle TR; Cone EJ; Schlienz NJ; Mitchell JM; Bigelow GE; Flegel R; Hayes E; Vandrey R
J Anal Toxicol; 2019 May; 43(4):233-258. PubMed ID: 30615181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
